Your session is about to expire
← Back to Search
Asthma Education for School Staff + Healthcare Providers for Childhood Asthma
N/A
Waitlist Available
Led By Bruce Bender, PhD
Research Sponsored by National Jewish Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Greater than or equal to 18 years of age
Be older than 18 years old
Must not have
Younger than 18 years of age, without presence of guardian
Timeline
Screening 3 weeks
Treatment Varies
Follow Up in-person interviews will be conducted with families during year five of the project.
Awards & highlights
Summary
This trial program will help to improve the health of children with asthma by training doctors, healthcare professionals, and school personnel in best practices. Families will also be educated on how to manage their child's asthma.
Who is the study for?
This trial is for guardians of children under 18 with asthma, living in Chinle, Tuba City, or Fort Defiance on the Navajo Nation. Participants must be able to give informed consent and understand English or Navajo. It's not open to those outside these areas or who can't consent.Check my eligibility
What is being tested?
The program aims to improve childhood asthma care on the Navajo Nation by training healthcare providers and school staff. It includes educating families about managing asthma and fostering collaboration between doctors, teachers, and families.See study design
What are the potential side effects?
Since this trial focuses on education and training rather than medication, there are no direct medical side effects. However, participants may experience changes in how they manage asthma based on new information.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 and do not have a guardian.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ in-person interviews will be conducted with families during year two of the project.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~in-person interviews will be conducted with families during year two of the project.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of pediatric asthma exacerbation in Year 4
Rate of pediatric asthma exacerbations in Year 1
Rate of pediatric asthma exacerbations in Year 2
+3 moreSecondary outcome measures
Community reports of asthma-related events Year 1
Asthma
Community reports of asthma-related events Year 3
+2 moreTrial Design
3Treatment groups
Active Control
Group I: Year two interventionActive Control2 Interventions
Both interventions will occur in the Tuba City Agency during year two.
Group II: Year three interventionActive Control2 Interventions
Both interventions will occur in the Chinle Agency during year three.
Group III: Year four interventionActive Control2 Interventions
Both interventions will occur in the Fort Defiance during year four.
Find a Location
Who is running the clinical trial?
National Jewish HealthLead Sponsor
141 Previous Clinical Trials
315,803 Total Patients Enrolled
University of ArizonaOTHER
518 Previous Clinical Trials
148,409 Total Patients Enrolled
1 Trials studying Childhood Asthma
442 Patients Enrolled for Childhood Asthma
Bruce Bender, PhDPrincipal InvestigatorNational Jewish Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am the guardian of a child under 18 with asthma.I am under 18 and do not have a guardian.
Research Study Groups:
This trial has the following groups:- Group 1: Year two intervention
- Group 2: Year three intervention
- Group 3: Year four intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger